Title

Criticism of best practice statement related to sodium-glucose cotransporter-2 inhibitors and serum potassium levels

Affiliations

Advocate Medical Group

Abstract

In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.

Document Type

Article

PubMed ID

33764438

DOI

10.1093/ajhp/zxab122

Link to Full Text

 

Share

COinS